SciELO - Scientific Electronic Library Online

 
vol.25 issue1T-Cell Large Granular Lymphocyte Leukemia: The Experience of a Single CenterVitamin D Metabolism and Pain in Rheumatoid Arthritis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Medicina Interna

Print version ISSN 0872-671X

Abstract

FREITAS, Ana Raquel et al. Audit of Compliance with Pharmacological Prophylaxis of Venous Thromboembolism in an Internal Medicine Department. Medicina Interna [online]. 2018, vol.25, n.1, pp.30-35. ISSN 0872-671X.  https://doi.org/10.24950/rspmi/original/163/1/2018.

Introduction: Venous thromboembolism (VTE) is the first cause of preventable intra-hospital death. The goal of this study was to evaluate the compliance of pharmacological prophylaxis of VTE in an Internal Medicine Department (IMD). This evaluation was based on a VTE risk assessment guide that was established as quality indicator. Material and Methods: Observational cross-sectional study between 2010 and 2016. The patients admitted to IMD on the first Friday of each month were included and hypocoagulated or absent patients on the third day of hospitalization were excluded. VTE risk assessment registry and prescription of prophylaxis on admission (D0) and on the third day (D3) were monitored. Adequacy rate of VTE prophylaxis (ratio between the number of patients undergoing appropriate prophylaxis and the total number of patients included) was calculated annually in D0 and D3. Results: A total of 569 patients were selected and 149 were excluded. Of the 420 patients included, 403 were considered at risk. Of these, 93.3% had a risk assessment registered in the clinical process at admission. Fifty-four patients had a contraindication for pharmacological prophylaxis. Of the 349 patients eligible for prophylaxis, 86.8% had adequate prescription on admission. There were few prescribing errors. In D0 the adequacy rate of pharmacological prophylaxis was 88.1% and in D3 87.6%. Conclusion: The risk assessment registry is widespread in IMD with a very considerable high percentage of pharmacological prophylaxis adequacy. The establishment of clinical guides and their systematic auditing allow a better understanding of reality and increase good practice, improving health organization.

Keywords : Hospitalization; Risk Assessment; Venous Thromboembolism; prevention & control.

        · abstract in Portuguese     · text in Portuguese     · Portuguese ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License